Table 2.

Model‐predicted clinical response rates following treatment with mobocertinib 160 mg q.d. and 120 mg q.d.

Outcome	Predictor	Predicted response rate, % (95% CI)		Odds ratio (95% CI)	P value
		160 mg q.d.	120 mg q.d.
Longitudinal clinical response (PR or better)	Normalized dynamic molar sum exposure	30.7 (23.2, 39.4)	27.9 (21.3, 35.8)	0.78 (0.55, 1.10)	0.156
Best confirmed response (PR or better)	Time‐averaged molar sum exposure	26.7 (19.3, 35.6)	24.5 (16.9, 34.1)	0.89 (0.71, 1.12)	0.316

CI, confidence interval; PR, partial response.